Tips for Vetting Partners | Third Party Due Diligence | Anti Corruption | UK Bribery Act | How Pharma is affected by Med Device Regulations, and vice versa | A Checklist for your Updated Compliance Program
This session is aimed at senior executives in pharmaceutical and medical device industries.
| Pharma Audiences | Medical Device Audiences |
| Pharmaceutical companies will learn about best practices in implementing a third party due diligence program in pharma as well as how regulations in the medical device space may effect pharma. | Medical device companies will learn best practices in implementing a third party due diligence program in the medical device industry as well as how regulations in pharma may effect the medical device space. |
This presentation will provide unique insights into what regulations in one industry may mean for the other. Join us as our experienced presenters discuss advice for mitigating risk when choosing and working with third party intermediaries and vendors.
The Following Key Talking Points and Insights will be Shared During the Presentation:
- Brief review of recent FCPA enforcement and guidance
- Overview of UK Bribery Act nuances and 'adequate procedures'
- Analysis of medical device industry guidelines for third party diligence
- Discussion of pharmaceutical industry best practices for third party diligence
- Advice for implementing a bulletproof third party diligence program
- A checklist for your updated compliance program
- Tips for vetting partners
- Strategies for prioritizing activities and effectively allocating resources
- Relevant case studies and hypothetical situations will provide clear examples of key concepts
Who Will Attend:
Senior Executives in legal and compliance departments at medical device and pharmaceutical companies
|
|||
|
|
